Assessment of neuromotor system and suprasegmentary vegetative structures in patients with systemic vasculitis (SV), systemic lupus erythematosus (SLE), scleroderma systematica (SS) for determination of the vegetative profile and pathogenetic links underlying vegetative disorders.
The examination of 125 rheumatic patients included clinical, laboratory, instrumental, neurological, neuropsychic, electroneuromyographic, vegetologic, pathomorphologic and biochemical investigations.
Rheumatic patients presented affections of the peripheral and central venous systems, vegetative dysfunction, disturbed higher nervous activity manifesting as polyneuropathy, mononeuropathy, pyramid syndrome, dystonia, hypothalamic syndrome, reduced adaptive ability, low tonicity of the sympathetic nervous system, terminal branches of the motor axons, etc.
Therapy of nervous disorders in rheumatic patients comprises treatment of cerebral circulation (vascular, nootropic drugs, cerebrolysin), asthenic, neurotic and vegetative disorders (sedative and vegetotropic drugs, etimisol, adaptogens), abnormalities of peripheral nervous system (amiridin, anticholinesterase preparations, vitamins B and others). Follow-up and correction of the on-going therapy contribute to a decrease in the number of invalidating and lethal neurological complications.